1. Two decades of orphan product development;Haffner;Nat Rev Drug Discov,2002
2. Orphan drug policies: implications for the United States, Canada, and developing countries;Cheung;Health Law J,2004
3. A cross-national comparison of orphan drug policies: implications for the U.S. Orphan Drug Act;Thamer;J Health Polit Policy Law,1998
4. MSPS. Assurer l’équité pour l’accès au diagnostic, au traitement et à la prise en charge. In: Plan National Maladies Rares 2005–2008. 2004.
5. CORD. Guiding documents. In: Towards a Canadian Orphan Drug Policy (ODP). 2005.